• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: April 24-28


ICYMI, this week we had stories about melanoma management with pembrolizumab, advances in rosacea therapy, new phase 2 data of VP-315 for BCC, and more.

Looking for Tax Advantages? Consider These 2 Asset Classes

Although our tax code changes somewhat regularly, both real estate and cash value life insurance have shown superior tax treatment for decades.

POLL: Are You Attending Revolutionizing Atopic Dermatitis (RAD)?

Click here to answer this week's poll.

The Mainstream Patient: April 24

This week's edition of the Mainstream Patient features stories about addictive behaviors stemming from skin care culture, the 21 best hyaluronic acid serums, and the struggles behind finding the right vitiligo treatment.

Delgocitinib Reduced Itch, Pain in Patients With Hand Eczema

When compared to a vehicle control cream, researchers said delgocitinib cream proved more efficacious.

Tranexamic Acid Injections May Be Efficacious in Acne Vulgaris

Researchers said the treatment may improve post-acne erythema.

Increased Risk of Suicide Attempts in Alopecia Areata Patients

The risk remained significantly increased for both sexes as well ,whether or not the patient had depression, substance use disorder, or alcohol use disorder.

The Liability of an Electronic Health Record System

At least 1 legal case suggests that providers have a duty to minimize risks during the transition period to a new electronic health record system.

Skin Changes, Thickness May Aid in Early Acromelagy Detection

With dermoscopy and skin thickness assessments, researchers said it may be possible to detect cutaneous-involved acromelagy.

Patients With Pressure Ulcers Face Compromised Skin Parameters

Such factors may include transepidermal water loss and skin barrier function.

Expert Advice for Dermatology Advanced Practice Providers Starting Their Career

Learning from mentors and developing a solid foundation in dermatology are just a few of the necessary steps to boost your career as a dermatology APP.

Four Abstracts on Eblasakimab and Farudodstat to be Presented at 1st International Societies for Investigative Dermatology Meeting

ASLAN Pharmaceuticals will present 2 late-breaking abstracts and 2 additional abstracts.

Discovering Dermatology Times: April 2023

Learn more about the in-depth topics covered in the April 2023 issue of Dermatology Times®.

Pointers With Portela: Why Does Vitamin C Serum Smell?

In this week’s Pointers with Portela, the 208SkinDoc explains why vitamin C serums can occasionally have an unpleasant smell.

Moderate-to-Severe Stress Associated With Skin Aging Manifestations

Patients more commonly reported skin aging manifestations when they experienced higher levels of stress.

FDA Gives the Green Light for Cheek Wrinkle Solution

Galderma announced the approval of a injectable poly-L-lactic acid to correct fine lines and wrinkles.

The Role of Exercise in Atopic Dermatitis, Spontaneous Urticaria

Physical activity and exercise may lead to improved mental health but exacerbate skin conditions.

New Class of Immunotherapy May Help Fight Aggressive Skin Cancer

The results of a new study reveal that the antibody works by activating the immune response to fight cancer and slows melanoma growth in mice.

What's Trending in Skin Care: April 2023

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of April.

Etanercept Improves Psoriasis Progression

Inhibitor etanercept alleviated pathological changes and inflammation in induced psoriasis.

Baricitinib Offers Hope for Pediatric Atopic Dermatitis Patients

Results of a new study indicate that baricitinib offers a potential therapeutic option with a favorable benefit-risk profile for pediatric patients with moderate-to-severe AD.

Proteomic and Molecular Changes in Cutaneous Melanoma Metastasis

Using mass spectrometry, researchers examined novel changes to gather updated metastasis information.

Sara’s Skin Security: Arm Them With Knowledge

Related Videos
© 2024 MJH Life Sciences

All rights reserved.